Unlocking the Potential of Gene Editing: Recent Progress of CRISPR/Cas9 Strategies to Transform Cardiovascular Therapeutics & Prevention

Time: 12:00 pm
day: Conference Day 1


• Navigating potential therapeutic indications for gene editing in the cardiovascular
disease space
• Delivery methods: Viral vectors vs lipid nanoparticles vs virus-like particles
• Illuminating strategies to assess efficacy and safety of gene editing